AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Overview Fund Activity
Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

83 hedge funds and large institutions have $37.3M invested in AVEO Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 25 closing their positions.

Holders
83
Holders Change
-16
Holders Change %
-16.16%
% of All Funds
1.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
22
Reduced
23
Closed
25
Calls
$3.86M
Puts
$1.37M
Net Calls
+$2.49M
Net Calls Change
-$6.19M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.97M
2
GCP
2
GSA Capital Partners
United Kingdom
$565K
3
AIM
3
Assured Investment Management
New York
$230K
4
WA
4
WealthTrust Axiom
Pennsylvania
$113K
5
ARTA
5
A.R.T. Advisors
New York
$85K

Top Sellers

1
GIM
1
Granahan Investment Management
Massachusetts
$0
2
6CM
2
683 Capital Management
New York
$0
3
BCM
3
Bridgeway Capital Management
Texas
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
FI
5
Fosun International
China
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of Montreal
101
Bank of Montreal
Ontario, Canada
– -$2K -151 Closed
IA
102
IFP Advisors
Florida
– -$1K -77 Closed
WEC
103
Winslow Evans & Crocker
Massachusetts
– -$2K -45 Closed
HR
104
Howe & Rusling
New York
– -$1K -35 Closed
1 2 3 4
5